Daniel Pipoly
Pulmonary Disease · Maumee, OHNPI 1598746125
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by United Therapeutics Corporation at 33.7% of the total. 2022 is the largest year on record at $683, 2.4 times the $290 reported in 2019. That places this record below the midpoint for pulmonary disease clinicians in OH, where the typical reported total is $1,293.
Across 90 payments — averaging $15.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- United Therapeutics Corporation$467
- Harmony Biosciences LLC$142
- Boehringer Ingelheim$97
- Sanofi$96
- AstraZeneca$88
- Genentech USA, Inc.$71
- plus $426 from 16 others
What the payments were for
- Consulting fees$71%
- Food & beverage$1,35197%
- Education$282%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| United Therapeutics Corporation | 36 | $467 |
| Harmony Biosciences LLC | 5 | $142 |
| Boehringer Ingelheim | 5 | $97 |
| Sanofi | 5 | $96 |
| AstraZeneca | 6 | $88 |
| Genentech USA, Inc. | 4 | $71 |
| Arbor Pharmaceuticals, Inc. | 4 | $60 |
| Insmed, Inc. | 3 | $45 |
| GSK | 3 | $38 |
| Electromed, Inc. | 3 | $32 |
| Advanced Respiratory, Inc | 2 | $31 |
| Amgen | 2 | $30 |
| Actelion Pharmaceuticals US, Inc. | 1 | $30 |
| Mylan Specialty L.p. | 2 | $28 |
| Johnson & Johnson | 2 | $25 |
| Grifols USA, LLC | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Novartis | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
| Baxter Healthcare | 1 | $12 |
| Z-medica, LLC | 1 | $7 |
How this compares
$1,386 in reported general payments places this provider in the 50th percentile of 571 pulmonary disease providers in Ohio.
Other pulmonary disease in Maumee
- Thamer SartawiMaumee$25K
- Joseph KhabbazaAkron$655K
- Robert BaughmanCincinnati$640K
- Kristin HighlandCleveland$551K
- Bruce CorserCincinnati$502K
- Jason StieneckerLima$397K
- Mohammad SheattCincinnati$389K
- Mohammad KhanAkron$388K
- Thomas YungerDayton$353K
- Joseph CiceniaCleveland$350K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.